Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients

Purpose: Genetically altered cells could become widespread across the epithelium of patients with oral cancer, often in clinically and histologically normal tissue, and contribute to recurrent disease. Molecular approaches have begun to yield information on cancer/risk fields; tissue optics could further extend our understanding of alteration to phenotype as a result of molecular change. Experimental Design: We used a simple hand-held device in the operating room to directly visualize subclinical field changes around oral cancers, documenting alteration to fluorescence. A total of 122 oral mucosa biopsies were obtained from 20 surgical specimens with each biopsy being assessed for location, fluorescence visualization (FV) status, histology, and loss of heterozygosity (LOH; 10 markers on three regions: 3p14, 9p21, and 17p13). Results: All tumors showed FV loss (FVL). For 19 of the 20 tumors, the loss extended in at least one direction beyond the clinically visible tumor, with the extension varying from 4 to 25 mm. Thirty-two of 36 FVL biopsies showed histologic change (including 7 squamous cell carcinoma/carcinomas in situ, 10 severe dysplasias, and 15 mild/moderate dysplasias) compared with 1 of the 66 FV retained (FVR) biopsies. Molecular analysis on margins with low-grade or no dysplasia showed a significant association of LOH in FVL biopsies, with LOH at 3p and/or 9p (previously associated with local tumor recurrence) present in 12 of 19 FVL biopsies compared with 3 of 13 FVR biopsies (P = 0.04). Conclusions: These data have, for the first time, shown that direct FV can identify subclinical high-risk fields with cancerous and precancerous changes in the operating room setting.

[1]  R. Richards-Kortum,et al.  Optimal Excitation Wavelengths for In Vivo Detection of Oral Neoplasia Using Fluorescence Spectroscopy¶ , 2000, Photochemistry and photobiology.

[2]  H Stepp,et al.  Autofluorescence imaging and spectroscopy of normal and malignant mucosa in patients with head and neck cancer , 1999, Lasers in surgery and medicine.

[3]  R. Richards-Kortum,et al.  Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. , 1998, Archives of otolaryngology--head & neck surgery.

[4]  G. Snow,et al.  Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor , 1994, Cancer.

[5]  M. Rosin,et al.  Molecular analysis of oral lichen planus. A premalignant lesion? , 1997, The American journal of pathology.

[6]  Pierre Lane,et al.  Direct fluorescence visualization of clinically occult high‐risk oral premalignant disease using a simple hand‐held device , 2007, Head & neck.

[7]  C. R. Leemans,et al.  Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  Ekaterina S. Svistun,et al.  Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence , 2004, Head & neck.

[9]  S. Lippman,et al.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.

[10]  N Ramanujam,et al.  In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm-excited laser-induced fluorescence. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Shapshay,et al.  Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma , 2003, Cancer.

[12]  L. Mao.  Can molecular assessment improve classification of head and neck premalignancy? , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  N D Le,et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  S. Lippman,et al.  Detection of chromosome instability of tissue fields at risk: In situ hybridization , 1996, Journal of cellular biochemistry. Supplement.

[15]  C. R. Leemans,et al.  Molecular Diagnosis of Surgical Margins and Local Recurrence in Head and Neck Cancer Patients , 2004, Clinical Cancer Research.

[16]  R R Alfano,et al.  In vivo native cellular fluorescence and histological characteristics of head and neck cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  W. Lam,et al.  3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. , 2002, Cancer research.

[18]  K Svanberg,et al.  In vivo fluorescence imaging for tissue diagnostics. , 1997, Physics in medicine and biology.

[19]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[20]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[21]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[22]  Haishan Zeng,et al.  Simple device for the direct visualization of oral-cavity tissue fluorescence. , 2006, Journal of biomedical optics.

[23]  R H Hruban,et al.  Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[24]  C. R. Leemans,et al.  Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer , 2004, Clinical Cancer Research.

[25]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[26]  Nhu D Le,et al.  Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. , 2005, Cancer research.

[27]  J. Califano,et al.  Intraoperative molecular margin analysis in head and neck cancer. , 2004, Archives of otolaryngology--head & neck surgery.

[28]  A E Profio,et al.  Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. , 1993, The Journal of thoracic and cardiovascular surgery.

[29]  I Itzkan,et al.  Autofluorescence characteristics of oral mucosa , 1997, Head & neck.

[30]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  S. Lippman,et al.  Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. , 2006, Cancer research.

[32]  Calum MacAulay,et al.  Laser-induced fluorescence spectroscopy at endoscopy: tissue optics, Monte Carlo modeling, and in vivo measurements , 1995 .